These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 25670519)

  • 21. Placebo, nocebo, and learning mechanisms.
    Colloca L
    Handb Exp Pharmacol; 2014; 225():17-35. PubMed ID: 25304524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neglect of sex: A call to action for including sex as a biological variable in placebo and nocebo research.
    Shafir R; Olson E; Colloca L
    Contemp Clin Trials; 2022 May; 116():106734. PubMed ID: 35306216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of placebo acupuncture over no-treatment: A simple model incorporating the placebo and nocebo effects.
    Koog YH
    Complement Ther Med; 2016 Feb; 24():69-72. PubMed ID: 26860804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classical conditioning without verbal suggestions elicits placebo analgesia and nocebo hyperalgesia.
    Bąbel P; Bajcar EA; Adamczyk W; Kicman P; Lisińska N; Świder K; Colloca L
    PLoS One; 2017; 12(7):e0181856. PubMed ID: 28750001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placebo and nocebo responses in drug trials of epilepsy.
    Zaccara G; Giovannelli F; Schmidt D
    Epilepsy Behav; 2015 Feb; 43():128-34. PubMed ID: 25703333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of the 'placebo effect' for CAM research.
    Relton C
    Complement Ther Med; 2013 Apr; 21(2):121-4. PubMed ID: 23497816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons to be learned from placebo arms in psychopharmacology trials.
    Doering BK; Rief W; Petrie KJ
    Handb Exp Pharmacol; 2014; 225():273-90. PubMed ID: 25304537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans.
    Bartels DJP; van Laarhoven AIM; Stroo M; Hijne K; Peerdeman KJ; Donders ART; van de Kerkhof PCM; Evers AWM
    PLoS One; 2017; 12(9):e0182959. PubMed ID: 28910291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychobiological Mechanisms of Placebo and Nocebo Effects: Pathways to Improve Treatments and Reduce Side Effects.
    Petrie KJ; Rief W
    Annu Rev Psychol; 2019 Jan; 70():599-625. PubMed ID: 30110575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can knowledge of Placebo and Nocebo Mechanisms Help Improve Randomized Clinical Trials?
    Carlino E; Vase L
    Int Rev Neurobiol; 2018; 138():329-357. PubMed ID: 29681333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Review of the Theoretical and Biological Understanding of the Nocebo and Placebo Phenomena.
    Dodd S; Dean OM; Vian J; Berk M
    Clin Ther; 2017 Mar; 39(3):469-476. PubMed ID: 28161116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials.
    Zis P; Hadjivassiliou M; Sarrigiannis PG; Jenkins TM; Mitsikostas DD
    J Neurol Sci; 2018 May; 388():79-83. PubMed ID: 29627036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing trial efficiency by early reallocation of placebo nonresponders in sequential parallel comparison designs: application to antidepressant trials.
    Boessen R; Knol MJ; Groenwold RH; Grobbee DE; Roes KC
    Clin Trials; 2012 Oct; 9(5):578-87. PubMed ID: 23060319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigating placebo effects in irritable bowel syndrome: a novel research design.
    Conboy LA; Wasserman RH; Jacobson EE; Davis RB; Legedza AT; Park M; Rivers AL; Morey EB; Nam BH; Lasagna L; Kirsch I; Lembo AJ; Kaptchuk TJ; Kerr CE
    Contemp Clin Trials; 2006 Apr; 27(2):123-34. PubMed ID: 16427366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nocebo effects in multiple sclerosis trials: a meta-analysis.
    Papadopoulos D; Mitsikostas DD
    Mult Scler; 2010 Jul; 16(7):816-28. PubMed ID: 20538704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The placebo-nocebo response in patients with depression: do we need to reconsider our treatment approach and clinical trial designs?
    Jakovljević M
    Psychiatr Danub; 2014 Jun; 26(2):92-5. PubMed ID: 24909243
    [No Abstract]   [Full Text] [Related]  

  • 37. How do nocebo effects in placebo groups of randomized controlled trials provide a possible explicative framework for the COVID-19 pandemic?
    Amanzio M; Cipriani GE; Bartoli M
    Expert Rev Clin Pharmacol; 2021 Apr; 14(4):439-444. PubMed ID: 33682603
    [No Abstract]   [Full Text] [Related]  

  • 38. Order does matter: the combined effects of classical conditioning and verbal suggestions on placebo hypoalgesia and nocebo hyperalgesia.
    Bajcar EA; Wiercioch-Kuzianik K; Farley D; Buglewicz E; Paulewicz B; Bąbel P
    Pain; 2021 Aug; 162(8):2237-2245. PubMed ID: 34256381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of conditioning and verbal suggestion in placebo and nocebo effects on itch.
    Bartels DJ; van Laarhoven AI; Haverkamp EA; Wilder-Smith OH; Donders AR; van Middendorp H; van de Kerkhof PC; Evers AW
    PLoS One; 2014; 9(3):e91727. PubMed ID: 24646924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocebo response in Parkinson's disease: A systematic review and meta-analysis.
    Leal Rato M; Duarte GS; Ferreira AN; Alves M; Mainoli B; Teodoro T; Mestre TA; Costa J; Ferreira JJ
    Parkinsonism Relat Disord; 2019 Aug; 65():13-19. PubMed ID: 31103487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.